TITLE

Cellular senescence in cancer treatment: friend or foe?

AUTHOR(S)
Kahlem, Pascal; Dörken, Bernd; Schmitt, Clemens A.; Pelicci, Pier Giuseppe
PUB. DATE
January 2004
SOURCE
Journal of Clinical Investigation;Jan2004, Vol. 113 Issue 2, p169
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Damage to DNA, the prime target of anticancer therapy, triggers programmed cellular responses. In addition to apoptosis, therapy-mediated premature senescence has been identified as another drug-responsive program that impacts the outcome of cancer therapy. Here, we discuss whether induction of senescence is a beneficial or, rather, a detrimental consequence of the therapeutic intervention.
ACCESSION #
12029108

 

Related Articles

  • Thiothymidine combined with UVA as a potential novel therapy for bladder cancer. Pridgeon, S. W.; Heer, R.; Taylor, G. A.; Newell, D. R.; O'Toole, K.; Robinson, M.; Xu, Y.-Z.; Karran, P.; Boddy, A. V. // British Journal of Cancer;6/7/2011, Vol. 104 Issue 12, p1869 

    Background:Thiothymidine (S4TdR) can be incorporated into DNA and sensitise cells to DNA damage and cell death following exposure to UVA light. Studies were performed to determine if the combination of S4TdR and UVA could be an effective treatment for bladder cancer.Methods:Uptake and...

  • Cellular Senescence as a Target in Cancer Control. Vergel, Mar; Marin, Juan J.; Estevez, Purificacion; Carnero, Amancio // Journal of Aging Research;2011, p1 

    Somatic cells show a spontaneous decline in growth rate in continuous culture. This is not related to elapsed time but to an increasing number of population doublings, eventually terminating in a quiescent but viable state termed replicative senescence. These cells are commonly multinucleated...

  • Novel functions of FoxM1: from molecular mechanisms to cancer therapy. Alvarez-Fernández, Mónica; Medema, René H.; Lanfrancone, Luisa; Condorelli, Gerolama // Frontiers in Oncology;Mar2013, Vol. 3, Special section p1 

    FoxM1 is a member of the forkhead family of transcription factors. Since its identification 15 year ago, numerous studies have progressively contributed to our current understanding on FoxM1 functions. Early work showed that FoxM1 regulates the transcriptional program of the G2 phase of the cell...

  • FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance. Khongkow, P; Karunarathna, U; Khongkow, M; Gong, C; Gomes, A R; Yagüe, E; Monteiro, L J; Kongsema, M; Zona, S; Man, E P S; Tsang, J W-H; Coombes, R C; Wu, K-J; Khoo, U-S; Medema, R H; Freire, R; Lam, E W-F // Oncogene;8/7/2014, Vol. 33 Issue 32, p4144 

    FOXM1 is implicated in genotoxic drug resistance but its mechanism of action remains elusive. We show here that FOXM1-depletion can sensitize breast cancer cells and mouse embryonic fibroblasts (MEFs) into entering epirubicin-induced senescence, with the loss of long-term cell proliferation...

  • Aggravated DNA damage as a basis for enhanced glioma cell killing by MJ-66 in combination with minocycline. Mann-Jen Hour; Wei-Ting Liu; I-Chen Lu; Sheng-Chu Kuo; Po-Wu Gean // American Journal of Cancer Research;2014, Vol. 4 Issue 5, p474 

    Despite recent advances in the treatment of malignant glomas, the prognosis of patients remains very poor and more efficient therapeutic approaches are urgently needed. In the present study, we investigated whether 2-(naphthalene-1-yl)-6-pyrrolidinyl-4-quinazolinone (MJ-66), a synthetic...

  • Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy. Byeong Mo Kim; Yunkyung Hong; Seunghoon Lee; Pengda Liu; Ji Hong Lim; Yong Heon Lee; Tae Ho Lee; Kyu Tae Chang; Yonggeun Hong // International Journal of Molecular Sciences;Nov2015, Vol. 16 Issue 11, p26880 

    Ionizing radiation (IR), such as X-rays and gamma (γ)-rays, mediates various forms of cancer cell death such as apoptosis, necrosis, autophagy, mitotic catastrophe, and senescence. Among them, apoptosis and mitotic catastrophe are the main mechanisms of IR action. DNA damage and genomic...

  • α-Catulin knockdown induces senescence in cancer cells. Fan, L-C; Chiang, W-F; Liang, C-H; Tsai, Y-T; Wong, T-Y; Chen, K-C; Hong, T-M; Chen, Y-L // Oncogene;6/9/2011, Vol. 30 Issue 23, p2610 

    Cellular senescence functions as a tumor suppressor that protects against cancer progression. α-Catulin, an α-catenin-related protein, is reported to have tumorigenic potential because it regulates the nuclear factor-κB (NF-κB) pathway, but little is known about its clinical...

  • Regulation of Senescence in Cancer and Aging. Yahui Kong; Hang Cui; Ramkumar, Charusheila; Hong Zhang // Journal of Aging Research;2011, p1 

    Senescence is regarded as a physiological response of cells to stress, including telomere dysfunction, aberrant oncogenic activation, DNA damage, and oxidative stress. This stress response has an antagonistically pleiotropic effect to organisms: beneficial as a tumor suppressor, but detrimental...

  • Transcriptional regulation of cellular senescence. Lanigan, F; Geraghty, J G; Bracken, A P // Oncogene;6/30/2011, Vol. 30 Issue 26, p2901 

    Cellular senescence is an irreversible arrest of proliferation. It is activated when a cell encounters stress such as DNA damage, telomere shortening or oncogene activation. Like apoptosis, it impedes tumour progression and acts as a barrier that pre-neoplastic cells must overcome during their...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics